We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.8B
AUM Growth
+$988M
Cap. Flow
+$812M
Cap. Flow %
7.54%
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$32.7M
2
LLY icon
Eli Lilly
LLY
+$31M
3
LZB icon
La-Z-Boy
LZB
+$17.4M
4
UI icon
Ubiquiti
UI
+$17.1M
5
TRS icon
TriMas Corp
TRS
+$16.1M

Top Sells

Rank Stock Value
1
LXU icon
LSB Industries
LXU
+$14M
2
K
Kellanova
K
+$13.7M
3
AAPL icon
Apple
AAPL
+$13.1M
4
PB icon
Prosperity Bancshares
PB
+$11.7M
5
FLR icon
Fluor
FLR
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Industrials 12.7%
3 Healthcare 12.22%
4 Financials 10.93%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNL icon
1676
WisdomTree Global ex-U.S. Quality Growth Fund
DNL
$468M
$25K ﹤0.01%
+1,000
New +$24.9K
FEZ icon
1677
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.28B
$25K ﹤0.01%
595
OC icon
1678
Owens Corning
OC
$11.5B
$25K ﹤0.01%
600
STLD icon
1679
Steel Dynamics
STLD
$35.6B
$25K ﹤0.01%
1,437
+21
+1% +$368
PWE
1680
DELISTED
Penn West Energy Petroleum Ltd
PWE
$25K ﹤0.01%
3,000
ENH.PRA
1681
DELISTED
ENDURANCE SPECIALTY HOLDINGS LTD PFD SER A
ENH.PRA
$25K ﹤0.01%
1,000
GSF.CL
1682
DELISTED
GOLDMAN SACHS GROUP INC 6.125% NTS DUE 2060
GSF.CL
$25K ﹤0.01%
1,000
THI
1683
DELISTED
TIM HORTONS INC COM, CANADA
THI
$25K ﹤0.01%
470
ACAD icon
1684
Acadia Pharmaceuticals
ACAD
$4.25B
$24K ﹤0.01%
1,000
BTE icon
1685
Baytex Energy
BTE
$3.08B
$24K ﹤0.01%
600
CMP icon
1686
Compass Minerals
CMP
$1.24B
$24K ﹤0.01%
300
DGRE icon
1687
WisdomTree Trust WisdomTree Emerging Markets Quality Dividend Growth Fund
DGRE
$140M
$24K ﹤0.01%
+1,000
New +$23.6K
FIW icon
1688
First Trust Water ETF
FIW
$1.84B
$24K ﹤0.01%
700
IRWD icon
1689
Ironwood Pharmaceuticals
IRWD
$611M
$24K ﹤0.01%
2,388
PSF icon
1690
Cohen & Steers Select Preferred & Income Fund
PSF
$235M
$24K ﹤0.01%
1,000
WAYN
1691
DELISTED
Wayne Savings Bancshares Inc
WAYN
$24K ﹤0.01%
2,125
FWM
1692
DELISTED
FAIRWAY GROUP HLDGS CORP CL A COM STK (DE)
FWM
$24K ﹤0.01%
3,190
DCT
1693
DELISTED
DCT Industrial Trust Inc.
DCT
$24K ﹤0.01%
764
FBG
1694
DELISTED
UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN
FBG
$24K ﹤0.01%
+525
New +$24K
FSTR icon
1695
Foster
FSTR
$443M
$23K ﹤0.01%
500
VCV icon
1696
Invesco California Value Municipal Income Trust
VCV
$515M
$23K ﹤0.01%
2,000
CVRR
1697
DELISTED
CVR Refining, LP
CVRR
$23K ﹤0.01%
1,000
PNRA
1698
DELISTED
Panera Bread Co
PNRA
$23K ﹤0.01%
139
JPM.PRC
1699
DELISTED
JPMORGAN CHASE CAPITAL XXIX 6.70% CAP SEC SERIES CC
JPM.PRC
$23K ﹤0.01%
915
ESC
1700
DELISTED
EMERITUS CORP
ESC
$23K ﹤0.01%
750

Similar funds

Glenmede Trust's Q1 2014 Portfolio in Review

As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.

  • Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
  • Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
  • Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
  • Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
  • Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
  • Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
  • Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.

Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.